Completion of First Clinical Cases using Bone Bolt System

The L. S. Peery, M.D. Orthopaedic Innovation Center at the Department of Orthopaedics, Spencer Fox Eccles School of Medicine, University of Utah, announced the successful completion of the first clinical cases using the Bone Bolt System at the University Orthopaedic Center, University of Utah.

Bone Bolt is a novel, FDA 510(k)-cleared implant system designed for percutaneous fixation of challenging bone fractures, including pelvic fractures and fractures of the long bones of the upper and lower extremities. Developed by the Orthopaedic Innovation Center, the system includes a family of implants of multiple lengths and diameters, supported by a dedicated instrumentation set and sterilization trays that enable streamlined operative workflows.

In a recent biomechanical study presented at the 2025 Orthopaedic Trauma Association Annual Meeting, posterior pelvic fractures stabilized with the Bone Bolt demonstrated more than 75% reduction in sagittal-plane fracture site instability after 10,000 simulated gait cycles, compared with fractures stabilized using traditional cannulated screws.

The Bone Bolt is currently being evaluated in a post-market multicenter prospective observational study led by principal investigator Lucas Marchand, M.D., Assistant Professor of Orthopaedics at the University of Utah. The study will compare outcomes of the Bone Bolt to cannulated screws in the treatment of lateral compression type-1 (LC1) pelvic fractures, the most common pelvic ring injury and one that represents over half of all pelvic ring fractures.

Primary and secondary outcome measures include:

• Post-operative pain, as measured by the Visual Analog Scale
• Post-operative mobility
• Healthy days at home
• Length of hospital stay

Bone Bolt is protected by U.S. Patent No. 11,553,948 with further U.S. and international patents pending. The Orthopaedic Innovation Center is actively engaging with medical device companies and strategic partners interested in licensing or acquiring rights to the Bone Bolt.

“For fractures where bilateral percutaneous access is possible, the Bone Bolt™ System provides enhanced mechanical stability compared to traditional cannulated screws,” said Justin Haller, M.D., Associate Professor of Orthopaedics at the University of Utah. “Improved stabilization has the potential to reduce post-operative pain and may allow patients to safely ambulate earlier in their recovery.”

“This technology platform reflects the University’s strength in translating orthopedic innovation into real-world solutions,” said Bruce Hunter, Chief Innovation Officer at the University of Utah’s Technology Licensing Office. “We’re poised to work with medical device companies and strategic partners to accelerate commercialization and expand access to these transformative technologies.”

Source: The L.S. Peery, M.D. Orthopaedic Innovation Center